Filed: 5/15/2024ACC: 0001583977-24-000002
📋 What this filing means
CORMORANT ASSET MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 57 equity positions with a total reported market value of $2.28B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
57
Positions
$2.28B
Total AUM (reported)
99.66M
Total Shares
Allocation by class
COM$1.20B52.6%
CLASS A ORD$426.66M18.7%
COM NEW$340.74M14.9%
COMMON STOCK$123.80M5.4%
SPON ADS$42.21M1.9%
ORDINARY SHARES$41.80M1.8%
SPONSORED ADS$36.81M1.6%
Portfolio Concentration
Top 3$692.94M30.4%
4–10$570.49M25.0%
11–25$576.69M25.3%
Rest$439.52M19.3%
Top 3 weight
30.4%
Top 10 weight
55.4%
Voting Authority Distribution
Total shares with voting rights: 99.66M
Sole
Full voting authority
99.66M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other57
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings57
Rows:
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares8.49M
TypeSH
Market value$426.66M
18.72%
Sole
8.49M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
DFNDShares6.89M
TypeSH
Market value$142.48M
6.25%
Sole
6.89M
Shared
0.00
None
0.00
ARCELLX INC
DFNDShares1.78M
TypeSH
Market value$123.80M
5.43%
Sole
1.78M
Shared
0.00
None
0.00
ALPINE IMMUNE SCIENCES INC
DFNDShares2.70M
TypeSH
Market value$107.03M
4.69%
Sole
2.70M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
DFNDShares3.20M
TypeSH
Market value$99.04M
4.34%
Sole
3.20M
Shared
0.00
None
0.00
PRAXIS PRECISION MEDICINES I
DFNDShares1.31M
TypeSH
Market value$79.94M
3.51%
Sole
1.31M
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
DFNDShares2.02M
TypeSH
Market value$79.46M
3.49%
Sole
2.02M
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
DFNDShares2.14M
TypeSH
Market value$77.76M
3.41%
Sole
2.14M
Shared
0.00
None
0.00
LONGBOARD PHARMACEUTICALS IN
DFNDShares3.35M
TypeSH
Market value$72.43M
3.18%
Sole
3.35M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
DFNDShares3.01M
TypeSH
Market value$54.84M
2.41%
Sole
3.01M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
DFNDShares1.15M
TypeSH
Market value$53.83M
2.36%
Sole
1.15M
Shared
0.00
None
0.00
BIOMEA FUSION INC
DFNDShares3.57M
TypeSH
Market value$53.38M
2.34%
Sole
3.57M
Shared
0.00
None
0.00
KORRO BIO INC
DFNDShares529.17K
TypeSH
Market value$47.63M
2.09%
Sole
529.17K
Shared
0.00
None
0.00
VAXCYTE INC
DFNDShares685K
TypeSH
Market value$46.79M
2.05%
Sole
685K
Shared
0.00
None
0.00
AUTOLUS THERAPEUTICS PLC
DFNDShares6.62M
TypeSH
Market value$42.21M
1.85%
Sole
6.62M
Shared
0.00
None
0.00
PHARVARIS N V
DFNDShares1.71M
TypeSH
Market value$39.55M
1.73%
Sole
1.71M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA COMPANY
DFNDShares1.50M
TypeSH
Market value$35.48M
1.56%
Sole
1.50M
Shared
0.00
None
0.00
CG ONCOLOGY INC
DFNDShares800K
TypeSH
Market value$35.12M
1.54%
Sole
800K
Shared
0.00
None
0.00
ALX ONCOLOGY HLDGS INC
DFNDShares3.14M
TypeSH
Market value$35.03M
1.54%
Sole
3.14M
Shared
0.00
None
0.00
BIOHAVEN LTD
DFNDShares616.96K
TypeSH
Market value$33.74M
1.48%
Sole
616.96K
Shared
0.00
None
0.00
MERUS N V
DFNDShares715K
TypeSH
Market value$32.20M
1.41%
Sole
715K
Shared
0.00
None
0.00
AEROVATE THERAPEUTICS INC
DFNDShares1.07M
TypeSH
Market value$31.63M
1.39%
Sole
1.07M
Shared
0.00
None
0.00
ABIVAX SA
DFNDShares2.13M
TypeSH
Market value$30.46M
1.34%
Sole
2.13M
Shared
0.00
None
0.00
HELIX ACQUISITION CORP II
DFNDShares2.91M
TypeSH
Market value$30.25M
1.33%
Sole
2.91M
Shared
0.00
None
0.00
MARINUS PHARMACEUTICALS INC
DFNDShares3.25M
TypeSH
Market value$29.38M
1.29%
Sole
3.25M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 8.49M | SH | $426.66M 18.72% | 8.49M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCDFND | COM NEW | 6.89M | SH | $142.48M 6.25% | 6.89M | 0.00 | 0.00 |
ARCELLX INCDFND | COMMON STOCK | 1.78M | SH | $123.80M 5.43% | 1.78M | 0.00 | 0.00 |
ALPINE IMMUNE SCIENCES INCDFND | COM | 2.70M | SH | $107.03M 4.69% | 2.70M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCDFND | COM | 3.20M | SH | $99.04M 4.34% | 3.20M | 0.00 | 0.00 |
PRAXIS PRECISION MEDICINES IDFND | COM NEW | 1.31M | SH | $79.94M 3.51% | 1.31M | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSDFND | COM NEW | 2.02M | SH | $79.46M 3.49% | 2.02M | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCDFND | COM | 2.14M | SH | $77.76M 3.41% | 2.14M | 0.00 | 0.00 |
LONGBOARD PHARMACEUTICALS INDFND | COM | 3.35M | SH | $72.43M 3.18% | 3.35M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCDFND | COM | 3.01M | SH | $54.84M 2.41% | 3.01M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INDFND | COM | 1.15M | SH | $53.83M 2.36% | 1.15M | 0.00 | 0.00 |
BIOMEA FUSION INCDFND | COM | 3.57M | SH | $53.38M 2.34% | 3.57M | 0.00 | 0.00 |
KORRO BIO INCDFND | COM | 529.17K | SH | $47.63M 2.09% | 529.17K | 0.00 | 0.00 |
VAXCYTE INCDFND | COM | 685K | SH | $46.79M 2.05% | 685K | 0.00 | 0.00 |
AUTOLUS THERAPEUTICS PLCDFND | SPON ADS | 6.62M | SH | $42.21M 1.85% | 6.62M | 0.00 | 0.00 |
PHARVARIS N VDFND | COM | 1.71M | SH | $39.55M 1.73% | 1.71M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA COMPANYDFND | ORDINARY SHARES | 1.50M | SH | $35.48M 1.56% | 1.50M | 0.00 | 0.00 |
CG ONCOLOGY INCDFND | COM | 800K | SH | $35.12M 1.54% | 800K | 0.00 | 0.00 |
ALX ONCOLOGY HLDGS INCDFND | COM | 3.14M | SH | $35.03M 1.54% | 3.14M | 0.00 | 0.00 |
BIOHAVEN LTDDFND | COM | 616.96K | SH | $33.74M 1.48% | 616.96K | 0.00 | 0.00 |
MERUS N VDFND | COM | 715K | SH | $32.20M 1.41% | 715K | 0.00 | 0.00 |
AEROVATE THERAPEUTICS INCDFND | COM | 1.07M | SH | $31.63M 1.39% | 1.07M | 0.00 | 0.00 |
ABIVAX SADFND | SPONSORED ADS | 2.13M | SH | $30.46M 1.34% | 2.13M | 0.00 | 0.00 |
HELIX ACQUISITION CORP IIDFND | CL A ORD SHS | 2.91M | SH | $30.25M 1.33% | 2.91M | 0.00 | 0.00 |
MARINUS PHARMACEUTICALS INCDFND | COM NEW | 3.25M | SH | $29.38M 1.29% | 3.25M | 0.00 | 0.00 |
Page 1 of 3